Barbenheimer Clash: Margot Robbie's 'Barbie' Grabs More Theaters Than Christopher Nolan's 'Oppenheimer'

Los Angeles, July 14 - The biggest box office battle heading into summer 2023, director Greta Gerwig's "Barbie" and Christopher Nolan's "Oppenheimer" is heating up ahead of their July 21st release. The stakes are high for the two most-anticipated movies that received high-flying reception from their respective premiers.

"Barbie", which stars Margot Robbie as the live-action form of the iconic fashion doll with Ryan Gosling as Ken, is expected to win the initial box office battle against "Oppenheimer" which is based on the 2005 biography American Prometheus by Kai Bird and Martin J. Sherwin about J. Robert Oppenheimer, the theoretical physicist who helped develop the first nuclear weapons on the Manhattan Project.



The Warner Bros. Pictures distribution, "Barbie" is projected to earn $75+ million while Universal Pictures' "Oppenheimer" is tracking $40+ million in their opening weekend. Ahead of the showdown begins, "Barbie" gets the upper hand over Nolan's directorial by striking more theaters in the domestic (North America) markets.

According to Hollywood reports, "Barbie" will officially open in 4100 theaters while "Oppenheimer" land in approx. 3600 theaters in the first week in North America. "Oppenheimer", however, will have access to all the IMAX screens available in North America as Paramount's "Mission: Impossible 7", which released on July 12, will have to drop its IMAX screens from July 21, as a part of the agreement.

"Oppenheimer" is anticipated to be an IMAX treat for the cine lovers and the movie has zero CGI shots, as confirmed by Nolan himself. The film stars Cillian Murphy as the title character, with a supporting ensemble cast including Emily Blunt, Matt Damon, Robert Downey Jr., Florence Pugh, Josh Hartnett, Casey Affleck, Rami Malek, and Kenneth Branagh.

The clash between "Barbie" and "Oppenheimer" is called Barbenheimer which is expected to bring huge crowds to theaters and is likely to have a long run at the box office.

Stay tuned...